Skip to main content
OpenTrials
Completed

NCT Number: NCT01135173

Waterpipe Cessation Intervention Study

The study is a two-group parallel arm randomized clinical trial, to be conducted at the Syrian Center for Tobacco Studies (SCTS) in Aleppo, Syria.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Syrian Center for Tobacco Studies

Aleppo, Syria

About this study

The study is a two-group parallel arm randomized clinical trial, to be conducted at the Syrian Center for Tobacco Studies (SCTS) in Aleppo, Syria. Subjects will be recruited by flyers, ads, and word of mouth. Smokers who are interested in receiving free stop-smoking assistance as part of a research study will be asked to contact the study office at the SCTS.

Eligibility will be determined by a brief phone screen to determine age, number of years as a smoker and current amount smoked per week, and medical history. Individuals who meet these requirements will be invited to an orientation/screening session at the SCTS to learn more about the study. At the orientation/screening session, the study will be described to interested individuals, their questions will be answered, and those interested in participating will be asked to sign the informed consent document. Participants then will provide baseline demographic information (age, gender, ethnicity, residence, marital status, education, occupation, income) and smoking related information (smoking history, level of dependence, interest in quitting, medical history), and answer other study questionnaires (e.g., self-efficacy, stages of change, and withdrawal symptoms, depression or mood scale). Body weight will be assessed with a calibrated balance-beam scale.

Participants will then be randomized to one of two intervention groups. Subjects in arm A will receive a brief (approximately 15 minute) motivational and educational intervention, delivered by a trained physician from the SCTS, plus written self-help materials. The self-help materials will be adapted and translated into Arabic from existing validated materials from the American Cancer Society and the University of Memphis School of Public Health.

Subjects in Arm B will receive behavioral counseling intervention conducted by a trained physician at the SCTS cessation clinic. Both self-help materials and behavioral intervention will be adapted from established clinical practice guidelines for cigarette smokers (Fiore et al., 2008), experience gained at SCTS with cigarette smokers, and information about the waterpipe gained from previous epidemiological, ethnographic, and clinical studies conducted by the SCTS. Subjects will be requested to do "homework" before the session to facilitate this process. Subjects will be asked to identify high-risk situations and difficulties in previous cessation attempts and will be walked through a series of suggestions in the event of a slip. We also will provide 3 brief (approximately 10 minute) phone calls to subjects during the 90 day follow-up period. These calls are used to identify early relapse, encourage participants, and provide support. In addition, they are used to review materials and information provided during the sessions.

All subjects (Arms A and B) will undergo follow-up assessment at 3 months post-cessation. Data collected at the 3-month follow-up will include expired air carbon monoxide level and several self-report measures, including smoking status, stage of change, and depressive symptomatology. In addition, subjects will be administered a semi-structured questionnaire to assess the perceived usefulness and appropriateness of several features of the cessation intervention (e.g., helpfulness of the interventionist and self-help materials, convenience of the timing and location of the sessions, and usefulness of the phone calls), along with suggestions for improving the intervention. All subjects will receive reminder phone call before the follow-up visits.

All intervention providers will undergo six hours of training for smoking cessation intervention counseling. This training will include general training on intervention delivery, based on current clinical practice standards in developed countries and specific training on study protocols using standardized intervention training materials developed at the University of Memphis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults (18-60 years)
  • regular water pipe smokers in Aleppo(at least twice per week for past year)
  • interested in quitting
  • access to a telephone

Exclusion criteria

  • unstable cardiovascular, psychiatric, or other debilitating diseases
  • inability to provide informed consent.

Treatment and study plan

Waterpipe smoking cessation

Behavioral

The main objective of this study is to compare two levels of intensity of a behavioral intervention for waterpipe smoking cessation, using a randomized controlled trial design. In this trial, brief motivational intervention with self-help materials will be compared with intensive behavioral counseling with four sessions, in order to test the efficacy of each of these interventions. This pilot testing will help us; 1) test the potential efficacy of the developed intervention, 2) fine-tune the intervention in terms of content and format, and 3) assess issues related to recruitment and retention. Thus, feedback from participants and intervention staff will form an essential part of this pilot study to assess the adopted approaches and suggest appropriate modifications.

Primary outcomes

  1. Smoking cessation

    Time frame: 3 months post-cessation

    The endpoint of cessation will be defined as no self-reported tobacco use, confirmed by expired carbon monoxide of less than 10ppm, at the 3 month post-cessation follow-up visit. Three indicators of cessation will be assessed, including prolonged abstinence (no smoking after two weeks post-quit date), continuous abstinence (no smoking after the quit date), and point-prevalent abstinence (no smoking for the past 7 days).

Secondary outcomes

  1. Stage of change

    Time frame: 3 months post-cessation

    Stage of change in the cessation process (pre-contemplation, contemplation, preparation, action, relapse) based on Prochaska & DiClemente's transtheoretical model.

  2. Depressive symptomatology

    Time frame: 3 months post-cessation

    Self-reported symptoms of depression, based on the CES-D

  3. Intervention acceptability

    Time frame: 3 months post-cessation

    Self-report process measures will be used to assess subject perceptions of helpfulness of the interventionist and self-help materials, convenience of the timing and location of intervention sessions, and usefulness of brief phone intervention contacts.

  4. Fagerström Test for Nicotine Dependence (FTND)

    Time frame: 3 months post-cessation

    To assess smokers'degree of nicotine dependence. Based on Heatherton TF et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86:1119-1127.

  5. Social Support

    Time frame: 3 months post-cessation

    To assess smokers'perceived social support. Based on Procidano ME & Heller K. Measures of perceived social support from friends and from family: three validation studies. Am J Community Psychol. 1983;11:1-24.

  6. Smoking-specific self-efficacy

    Time frame: 3 months post-cessation

    To assess smokers' confidence in his/her ability to keep from smoking in a range of different situations. Based on Velicer WF et al. Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15:271-283.

Sponsors and collaborators

Lead sponsor

University of Memphis

Other

Registry information

Official study title

Pilot Test of a Cessation Intervention for Waterpipe Smokers

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
Jun 2, 2010
Registry last updated
Jun 10, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.